China Pharma Holdings (CPHI) Change in Intangibles (2010 - 2014)
China Pharma Holdings' (CPHI) quarterly Change in Intangibles came in at -$470624.0 in Q4 2014, down 337.69% YoY from $198003.0 in Q4 2013, and down 337.69% on a QoQ basis from $198003.0 in Q4 2013.
China Pharma Holdings (CPHI) Change in Intangibles (2010 - 2014) Analysis & Trends
China Pharma Holdings (CPHI) has 5 years of Change in Intangibles data on file, last reported at -$470624.0 in Q4 2014.
- Quarterly Change in Intangibles fell 337.69% year-over-year to -$470624.0 in Q4 2014, while the trailing twelve-month figure through Dec 2014 was $3.3 million (up 10.63% YoY) and the FY2014 annual result came in at -$714697.0, down 139.32% from the prior year.
- Change in Intangibles declined to -$470624.0 in Q4 2014, from $198003.0 in the prior quarter.
- In the past five years, Change in Intangibles ranged from a high of $4.1 million in Q3 2013 to a low of -$4.9 million in Q3 2010.
- A 5-year average of -$1.0 million and a median of -$790092.0 in 2012 frame the typical range for Change in Intangibles.
- Annual changes were most pronounced in 2011 — Change in Intangibles jumped 75.71% — and 2012, when it sank 705.78%.
- Tracing CPHI's Change in Intangibles over 5 years: stood at -$3.5 million in 2010, then jumped by 75.71% to -$856895.0 in 2011, then jumped by 43.95% to -$480307.0 in 2012, then jumped by 141.22% to $198003.0 in 2013, then sank by 337.69% to -$470624.0 in 2014.
- The last three Change in Intangibles figures came in at -$470624.0 (Q4 2014), $198003.0 (Q4 2013), and $4.1 million (Q3 2013), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Intangibles (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 44.51 Bn | 43.55 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.52 Bn | 39.86 Bn | 2.15 Bn | - |
| 3 | Zoetis | 32.43 Bn | 30.75 Bn | 1.05 Bn | - |
| 4 | Takeda Pharmaceutical | 28.63 Bn | 22.83 Bn | 5.10 Bn | -310.09 Mn |
| 5 | United Therapeutics | 21.87 Bn | 19.21 Bn | 683.80 Mn | - |
| 6 | Viatris | 18.98 Bn | 18.09 Bn | 1.46 Bn | - |
| 7 | Neurocrine Biosciences | 15.43 Bn | 15.04 Bn | 935.80 Mn | - |
| 8 | Elanco Animal Health | 12.02 Bn | 11.49 Bn | 798.00 Mn | - |
| 9 | Dr Reddys Laboratories | 10.14 Bn | 9.98 Bn | - | - |
| 10 | China Pharma Holdings | 39.71 Mn | 39.41 Mn | 83,566.00 | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2014 | -470,624.00 |
| Dec 31, 2014 | -470,624.00 |
| Dec 31, 2013 | 198,003.00 |
| Dec 31, 2013 | 198,003.00 |
| Sep 30, 2013 | 4.08 Mn |
| Sep 30, 2013 | 4.08 Mn |
| Jun 30, 2012 | -480,307.00 |
| Jun 30, 2012 | -480,307.00 |
| Mar 31, 2012 | -790,092.00 |
| Mar 31, 2012 | -790,092.00 |
| Dec 31, 2011 | -856,895.00 |
| Dec 31, 2011 | -856,895.00 |
| Sep 30, 2011 | -3.43 Mn |
| Sep 30, 2011 | -3.43 Mn |
| Jun 30, 2011 | -59,608.00 |
| Jun 30, 2011 | -59,608.00 |
| Mar 31, 2011 | -843,378.00 |
| Mar 31, 2011 | -843,378.00 |
| Dec 31, 2010 | -3.53 Mn |
| Dec 31, 2010 | -3.53 Mn |